PetIQ, Inc. (PETQ) Tops Q4 EPS by 12c, Revs In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
PetIQ, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results
March 13, 2018 4:05 PM EDTEAGLE, Idaho, March 13, 2018 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (NASDAQ: PETQ), a leading pet medication and wellness company, today reported financial results for its fourth quarter and year ended December 31, 2017.
Fourth Quarter 2017 Highlights Compared to Prior Year Period
Net sales were $51.9 million, an increase of 15.6% year-over-yearNet loss was $3.4 millionAdjusted net income increased $3.7 million to $2.6 millionAdjusted EBITDA increased $2.0 million to $3.6 million, an increase of 132% year-over-yearFull Year 2017 Highlights Compared to Prior Year
Net sales were $266.7 million, an increase of 33.2%... More


